MedTrace Logo

Comparison of Accidents and Their Circumstances With Oral Anticoagulants

NCT02376777 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4162

Last updated 2017-06-28

No results posted yet for this study

Summary

Differences in efficacy and safety between new oral anticoagulants (NOAC) and vitamin K antagonist (VKA) in real practice remain uncertain.

The few existing ambulatory studies did not answer all NOAC specific issues, such as prescription habits and motives, patients characteristics, biological monitoring, as well as the occurrence of major and minor thromboembolic events, especially in France where warfarin is less frequently prescribed.

Therefore, in order to describe clinical and follow up characteristics of patients receiving oral anticoagulants, the investigators will set up a national prospective cohort to compare the occurrence of thromboembolic events between VKA and NOAC in primary care.

Conditions

Interventions

OTHER

Follow up

each three months during one year of follow up, general practioners will entered health data in database (hemorrhagic events, changes of medication, biological data...)

Sponsors & Collaborators

  • Floralis

    collaborator INDUSTRY

  • University Hospital, Grenoble

    collaborator OTHER

  • CNGE IRMG Association

    lead OTHER

Principal Investigators

  • Joël COGNEAU, MD · IRMG

  • Paul FRAPPE, MD · University of Saint-Etienne

  • Jean-Pierre JACQUET, MD · University of Grenoble

  • Jean-Luc BOSSON, MD PhD · University of Grenoble

  • François Lacoin, MD · IRMG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-12-31
Completion
2017-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02376777 on ClinicalTrials.gov